Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR T-Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Not applicableUnknownNCT03327285
What this trial is testing

C-CAR011 Treatment in Subjects With ALL After HSCT

Who this might be right for
Acute Lymphoblastic Leukemia(ALL)
Peking University People's Hospital 40
Early research (Phase 1)Not Yet RecruitingNCT06913179
What this trial is testing

CAR-T Cell Therapy Combined With Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Xuzhou Medical University 30
Early research (Phase 1)UnknownNCT03114670
What this trial is testing

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Who this might be right for
Adult Acute Myeloid Leukemia
Affiliated Hospital to Academy of Military Medical Sciences 20
Testing effectiveness (Phase 2)Ended earlyNCT02794246
What this trial is testing

CART-19 Post-ASCT for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 6
Large-scale testing (Phase 3)Looking for participantsNCT07764978
What this trial is testing

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

Who this might be right for
Newly Diagnosed Multiple Myeloma
AstraZeneca 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT05234190
What this trial is testing

Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

Who this might be right for
Rejection; Transplant, LiverLiver FailureLiver Diseases
Quell Therapeutics Limited 33
Not applicableLooking for participantsNCT06802406
What this trial is testing

Nutrition OUtReach In Systems of Healthcare

Who this might be right for
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONAutologous Haemopoietic Stem Cell TransplantCAR-T Cell Therapy+1 more
University of Kansas Medical Center 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT05860036
What this trial is testing

VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06045806
What this trial is testing

Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Celgene 79
Early research (Phase 1)Study completedNCT01087294
What this trial is testing

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, B-cellLymphoma, HodgkinsLymphoma, Non-hodgkins+1 more
National Cancer Institute (NCI) 85
Early research (Phase 1)WithdrawnNCT03768310
What this trial is testing

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Who this might be right for
Non-hodgkin LymphomaAcute Lymphoblastic Leukemia
Baylor College of Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT07106736
What this trial is testing

MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Institute of Hematology & Blood Diseases Hospital, China 60